Company Filing History:
2 out of 832,812 Years Active: 2016-2017
Title: Johanna Lampe: Innovator in Oncolytic Virus Research
Introduction
Johanna Lampe is a prominent inventor based in Helsinki, Finland. She has made significant contributions to the field of pharmaceutical compositions, particularly in the development of oncolytic viruses for cancer treatment. With a total of 2 patents, her work is paving the way for innovative therapies in oncology.
Latest Patents
Johanna's latest patents focus on the use of a recombinant measles virus encoding a suicide gene. This invention aims to treat malignant cells that exhibit primary or secondary resistance against an oncolytic measles virus without suicide gene activity. The patent also details a recombinant measles virus based on the measles vaccine strain Schwarz, which encodes a suicide gene. This includes a fusion of cytosine deaminase and uracil phosphoribosyltransferase, providing a method and kit for preparing the recombinant measles virus.
Career Highlights
Throughout her career, Johanna has demonstrated a commitment to advancing medical science through her innovative research. Her work has the potential to transform cancer treatment and improve patient outcomes.
Collaborations
Johanna collaborates with notable colleagues, including Ulrich Manfred Lauer and Michael Bitzer. Their combined expertise enhances the research and development of her groundbreaking inventions.
Conclusion
Johanna Lampe is a trailblazer in the field of oncolytic virus research, with her patents representing significant advancements in cancer therapy. Her contributions are vital to the ongoing fight against cancer, showcasing the importance of innovation in medicine.